Wu X - Search Results

1

Development of novel chromeno[4,3-c]pyrazol-4(2H)-one derivates containing piperazine as inhibitors of PI3Kα.

Yin Y, Zhou Y, Sha S, Wu X, Wang SF, Qiao F, Song ZC, Zhu HL. Yin Y, et al. Among authors: wu x. Bioorg Chem. 2019 Nov;92:103238. doi: 10.1016/j.bioorg.2019.103238. Epub 2019 Aug 30. Bioorg Chem. 2019. PMID: 31499259

2

Synthesis, molecular docking and biological evaluation of metronidazole derivatives containing piperazine skeleton as potential antibacterial agents.

Wang SF, Yin Y, Qiao F, Wu X, Sha S, Zhang L, Zhu HL. Wang SF, et al. Among authors: wu x. Bioorg Med Chem. 2014 Apr 15;22(8):2409-15. doi: 10.1016/j.bmc.2014.03.004. Epub 2014 Mar 13. Bioorg Med Chem. 2014. PMID: 24680059

3

Design, synthesis and biological evaluation of (E)-3-(3,4-dihydroxyphenyl)acrylylpiperazine derivatives as a new class of tubulin polymerization inhibitors.

Yin Y, Qiao F, Jiang LY, Wang SF, Sha S, Wu X, Lv PC, Zhu HL. Yin Y, et al. Among authors: wu x. Bioorg Med Chem. 2014 Aug 1;22(15):4285-92. doi: 10.1016/j.bmc.2014.05.029. Epub 2014 May 21. Bioorg Med Chem. 2014. PMID: 24916028

4

Discovery and synthesis of a novel series of potent, selective inhibitors of the PI3Kα: 2-alkyl-chromeno[4,3-c]pyrazol-4(2H)-one derivatives.

Yin Y, Wu X, Han HW, Sha S, Wang SF, Qiao F, Lu AM, Lv PC, Zhu HL. Yin Y, et al. Among authors: wu x. Org Biomol Chem. 2014 Dec 7;12(45):9157-65. doi: 10.1039/c4ob01589d. Org Biomol Chem. 2014. PMID: 25296388

5

Synthesis, molecular docking and biological evaluation of coumarin derivatives containing piperazine skeleton as potential antibacterial agents.

Wang SF, Yin Y, Wu X, Qiao F, Sha S, Lv PC, Zhao J, Zhu HL. Wang SF, et al. Among authors: wu x. Bioorg Med Chem. 2014 Nov 1;22(21):5727-37. doi: 10.1016/j.bmc.2014.09.048. Epub 2014 Sep 30. Bioorg Med Chem. 2014. PMID: 25306465

6

6,7-Dihydrobenzo[f]benzo[4,5]imidazo[1,2-d][1,4]oxazepine derivatives as selective inhibitors of PI3Kα.

Yin Y, Zhang YQ, Jin B, Sha S, Wu X, Sangani CB, Wang SF, Qiao F, Lu AM, Lv PC, Zhu HL. Yin Y, et al. Among authors: wu x. Bioorg Med Chem. 2015 Mar 15;23(6):1231-40. doi: 10.1016/j.bmc.2015.01.052. Epub 2015 Feb 7. Bioorg Med Chem. 2015. PMID: 25693787

7

Discovery of new 4-alkoxyquinazoline-based derivatives as potent VEGFR2 inhibitors.

Yin Y, Sha S, Wang YT, Wu X, Wang SF, Qiao F, Lv PC, Zhu HL. Yin Y, et al. Among authors: wu x. Chem Biol Drug Des. 2015 Nov;86(5):1323-9. doi: 10.1111/cbdd.12596. Epub 2015 Jun 23. Chem Biol Drug Des. 2015. PMID: 26032487

8

Development of novel chromeno[4,3-c]pyrazol-4(2H)-one derivates bearing sulfonylpiperazine as antitumor inhibitors targeting PI3Kα.

Yin Y, Sha S, Wu X, Wang SF, Qiao F, Song ZC, Zhu HL. Yin Y, et al. Among authors: wu x. Eur J Med Chem. 2019 Nov 15;182:111630. doi: 10.1016/j.ejmech.2019.111630. Epub 2019 Aug 18. Eur J Med Chem. 2019. PMID: 31446244

9

Aerobic exercise regulates gut microbiota profiles and metabolite in the early stage of Alzheimer's disease.

Wei C, Wu X, Li C, Zhang Y, Yuan Q, Huang R. Wei C, et al. Among authors: wu x. FASEB J. 2025 Jan 31;39(2):e70327. doi: 10.1096/fj.202402572R. FASEB J. 2025. PMID: 39831888

10

GSDMB modulates intestinal epithelial homeostasis via regulating hyperactive unfolded protein response in Crohn's disease.

Gong W, Liu P, Liu J, Li Y, Jiang H, Li W, Kang J, Jiao F, Wu X, Zhao Y, Ren J. Gong W, et al. Among authors: wu x. J Crohns Colitis. 2025 Jan 20:jjaf012. doi: 10.1093/ecco-jcc/jjaf012. Online ahead of print. J Crohns Colitis. 2025. PMID: 39831701

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59,333 results

Search Page

Filters